Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results

Go back to Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results

Allscripts (MDRX) Tops Q4 EPS by 54c

February 24, 2022 4:04 PM EST

Allscripts (NASDAQ: MDRX) reported Q4 EPS of $0.79, $0.54 better than the analyst estimate of $0.25. Revenue for the quarter came in at $392 million versus the consensus estimate of $386.75 million.

GUIDANCE:

For the full year 2022, Allscripts currently expects to achieve:

Consolidated free cash flow from... More